North Point Portfolio Managers Corp Bristol Myers Squibb CO Transaction History
North Point Portfolio Managers Corp
- $590 Million
- Q3 2024
A detailed history of North Point Portfolio Managers Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, North Point Portfolio Managers Corp holds 5,287 shares of BMY stock, worth $292,265. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,287Holding current value
$292,265% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,457Shares Held
1.5BCall Options Held
29.6MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.3 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.77 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.06 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.13 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.26 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $118B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...